Table 1.
Effects of LC and/or GB treatment on body weight, serum glucose homeostasis, and liver enzymes.
| Groups | Body Weight | Glucose (mg/L) | Insulin (uIU/mL) | HOMA-IR | ALT(U/L) | AST (U/L) |
|---|---|---|---|---|---|---|
| Control | 157.67 ± 5.28 | 86.17 ± 8.1 | 16.67 ± 1.15 | 3.73 ± 0.39 | 48.17 ± 4.67 | 94.5 ± 9.42 |
| HCD | 259.83 ± 5.27 acde | 138.22 ± 4.22 acde | 21.6 ± 3.51 e | 5.1 ± 0.55 a | 91.67 ± 4.18 acde | 166 ± 11.08 acde |
| HCD + LC | 218.83 ± 3.43 abe | 119.12 ± 4.02 abe | 18.83 ± 2.52 | 4.88 ± 0.46 a | 62.5 ± 5.86 ab | 118 ± 8.74 ab |
| HCD + GB | 228 ± 7.48 abe | 119.28 ± 4.83 abe | 16.63 ± 1.31 | 4.78 ± 0.48 a | 62 ± 5.18 ab | 118.33 ± 5.47 abc |
| HCD + LC + GB | 191.83 ± 5.19 abcd | 94.76 ± 3.79 bcd | 15.23 ± 1.68 b | 4.087 ± 0.44 | 55 ± 4 b | 113.33 ± 3.72 ab |
All values are expressed as the mean ± SD; HOMA-IR: homeostatic model assessment for insulin resistance; ALT: alanine aminotransferase; AST: aspartate aminotransferase. The superscript letters a, b, c, d, and e indicate significant differences (p-value < 0.05) between groups in comparison with the control, HCD, HCD + LC, HCD + GB, and HCD + LC + GB groups, respectively.